Enoxaparin Versus Unfractionated Heparin in PCI

• Status: Completed
• Trial end date: 2006-02-01
• Target enrollment: 0
• Participant gender: All

Summary

Enoxaparin 0.75mg/kg BW is not inferior to weight adjusted unfractionated heparin as anticoagulation for PCI

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Triemli Hospital
• Treatments: Calcium heparin; Enoxaparin; Heparin

Criteria

Inclusion Criteria:

• PCI for stable ischemia or ACS

Exclusion Criteria:

• Cardiogenic shock,

• Pretreatment with study drugs,

• Lack of informed consent